Scientific instruments manufacturer Formulaction has been acquired by Microtrac MRB, a Verder Group company
Microtrac MRB, the particle characterization segment of Verder Group, has acquired Formulaction, which will be integrated into the group’s scientific division.
Founded in 1994 by Gérard Meunier, Formulaction is a manufacturer of cutting-edge instrumentation used in research and development for the characterization of physical stability, particle size, phase transitions and rheological properties of liquid dispersions. Formulaction is the inventor of Turbiscan, the world reference in stability analysis. The company employs 36 people and is headquartered in Toulouse, France, supported by two subsidiaries in Columbus, Ohio, in the USA and Aichach, Germany.
Microtrac MRB is a subsidiary of Verder Group. A leading manufacturer of particle characterization instruments and technologies, Microtrac MRB’s products are used for measuring and analyzing particle size, shape, surface area and other properties in various industries, including pharmaceuticals, chemicals, minerals and materials research.
Verder Group is a global industrial company that specializes in manufacturing and distributing high-quality equipment and solutions for various industries, including laboratory, process and fluid handling. The group offers a wide range of products, such as pumps, mixers, samplers and analytical instruments.
After 25 years of development, Formulaction’s founder Gérard Meunier started to transfer responsibilities to key managers three years ago, anticipating the transaction for the group. After a competitive process involving strategic acquirors from all over the world, Verder Group was chosen as the best strategic fit to work alongside the company’s management. Verder Group has acquired 100% of shares.
Oaklins’ team in France served as the exclusive financial advisor to Formulaction’s shareholders throughout the sale process. The team approached several acquirors worldwide and negotiated the most attractive deal for the sellers.
Gérard Meunier
Founder, Formulaction
Sprechen Sie mit dem Deal Team
Transaktionen
Die Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.
Mehr erfahrenThe assets of IMG have been acquired by SLV Mecklenburg-Vorpommern
The assets of Ingenieurtechnik und Maschinenbau GmbH (IMG) have been acquired by SLV Mecklenburg-Vorpommern GmbH (SLV-MV) through an asset deal as part of IMG’s insolvency proceedings.
Mehr erfahrenLauak Group has sold a majority stake to Wipro Infrastructure Engineering
After careful strategic reflection to secure the group’s future, Lauak Group’s shareholders have chosen an industrial partnership, in line with the ongoing consolidation trend in the market. Attracted by opportunities for innovation and international expansion, the Charritton family, founders and long-term shareholders, regard Wipro Infrastructure Engineering as a trusted industrial partner. The historical shareholders remain minority stakeholders, and the current CEO continues to lead Lauak.
Mehr erfahren